This distinction is functionally important in cancer, in which reduction in macroH2A1.1 occurs in several tumor types and the alteration in macroH2A1.1 expression has important effects on both the proliferation and metastatic potential of cancer cells [18, 28]. The gene discussed is MACROH2A1; the disease is cancer.